Research progress on influencing factors and intervention of phosphate
binder medication adherence in hemodialysis patients

doi:10.3760/cma.j.issn.1007-1245.2022.20.010

Abstract

Abstract: This article introduces the epidemiology and status quo of medication adherence of hemodialysis patients with hyperphosphatemia, analyzes the influencing factors of phosphate binder medication adherence in patients with hyperphosphatemia at home and abroad, and explores the intervention measures for medication adherence, in order to provide references for medical staff to take measures to improve the medication adherence in hemodialysis patients with hyperphosphatemia.

Key words: Hemodialysis, Hyperphosphatemia, Phosphate binder, Medication adherence

摘要： 介绍血液透析伴高磷血症的流行病学和服药依从性的现状，分析国内外高磷血症患者服用磷结合剂依从性的影响因素，并探讨其用药依从性的干预措施，以期为医护人员采取措施提高血液透析伴高磷血症患者的服药依从性提供参考。

关键词: 血液透析, 高磷血症, 磷结合剂, 服药依从性

Peng Mingmei, Cai Xiaoyan, Yang Yuli, Cao Rui. Research progress on influencing factors and intervention of phosphate binder medication adherence in hemodialysis patients[J]. International Medicine and Health Guidance News, 2022, 28(20): 2863-2867.

彭明媚蔡小燕杨玉丽曹锐. 血液透析患者服用磷结合剂依从性的影响因素及干预研究进展[J]. 国际医药卫生导报, 2022, 28(20): 2863-2867.

References

[1] Vervloet MG, Sezer S, Massy ZA, et al. The role of phosphate in kidney disease[J]. Nat Rev Nephrol,2017,13(1):27-38. DOI: 10.1038/nrneph.2016.164.
[2] Liu ZH, Yu XQ, Yang JW, et al. Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study[J]. Curr Med Res Opin,2018,34(8):1491-1500. DOI:10.1080/03007995.2018.1467886.
[3] Zhao X, Niu Q, Gan L, et al. Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS)[J]. Sci Rep,2021,11(1):873. DOI:10.1038/s41598-020-79531-4.
[4] Tonelli M, Pannu N, Manns B. Oral phosphate binders in patients with kidney failure[J]. N Engl J Med,2010,362(14):1312-1324. DOI:10.1056/NEJMc1005274.
[5] De las Cuevas C. Towards a clarification of terminology in medicine taking behavior: compliance, adherence and concordance are related although different terms with different uses[J]. Curr Clin Pharmacol,2011,6(2):74-77. DOI:10.2174/157488411796151110.
[6] Karamanidou C, Clatworthy J, Weinman J, et al. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease[J]. BMC Nephrol,2008,9:2. DOI:10.1186/1471-2369-9-2.
[7] Ghimire S, Castelino RL, Lioufas NM, et al. Nonadherence to medication therapy in haemodialysis patients: a systematic review[J]. PLoS One,2015,10(12):e144119. DOI:10.1371/journal.pone.0144119.
[8] 何茂芯,杨玉洁. 维持性血液透析患者服用磷结合剂依从性调查分析[J]. 护理学杂志,2020,35(8):39-41. DOI:10.3870/j.issn.1001-4152.2020.08.039.
[9] 岳晓红,薛莹,司方莹. 维持性血液透析患者磷结合剂用药依从性影响因素研究与药学干预[J]. 中国药房,2021,32(8):1003-1008. DOI:10.6039/j.issn.1001-0408.2021.08.18.
[10] Lloret MJ, Ruiz-Garcia C, Dasilva I, et al. Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence[J]. Patient Prefer Adherence,2013,7:1147-1156. DOI:10.2147/PPA.S31694.
[11] Alfieri C, Malberti F, Mazzaferro S, et al. Hyperphosphatemia in dialysis: which binder?[J]. G Ital Nefrol,2018, 35(5):2018-vol5.
[12] Sawin DA, Ma L, Stennett A, et al. Phosphates in medications: impact on dialysis patients[J]. Clin Nephrol,2020,93(4):163-171. DOI:10.5414/CN109853.
[13] Chen N, Wu X, Ding X, et al. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study[J]. Nephrol Dial Transplant,2014,29(1):152-160. DOI:10.1093/ndt/gft232.
[14] Takayama S, Oda M, Saitoh H. Investigation of leftover hyperphosphatemia drugs in hemodialysis outpatients[J]. Yakugaku Zasshi,2021,141(3):433-440. DOI:10.1248/yakushi.20-00152.
[15] Kasai S, Sato K, Murata Y, et al. Randomized crossover study of the efficacy and safety of sevelamer hydrochloride and lanthanum carbonate in Japanese patients undergoing hemodialysis[J]. Ther Apher Dial,2012,16(4):341-349. DOI:10.1111/j.1744-9987.2012. 01071.x.
[16] Fujimoto D, Miyagi A, Tamura U, et al. Early gastric cancer with lanthanum deposition mucosa by endoscopic submucosal dissection: a case report and literature review[J]. Clin J Gastroenterol,2021,14(5):1344-1349. DOI:10.1007/s12328-021-01453-z.
[17] Cernaro V, Calimeri S, Laudani A, et al. Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease[J]. Ther Clin Risk Manag,2020,16:871-880. DOI:10.2147/TCRM.S196805.
[18] Ohya M, Iwashita Y, Kunimoto S, et al. An analysis of medication adherence and patient preference in long-term stable maintenance hemodialysis patients in Japan[J]. Intern Med,2019,58(18):2595-2603. DOI:10.2169/internalmedicine.2676-19.
[19] 郝桂华,黄梅娟,黄洁,等. 维持性血液透析患者口服醋酸钙依从性调查及其相关因素分析[J]. 中华现代护理杂志,2017,23(26):3416-3419. DOI:10.3760/cma.j.issn.1674-2907.2017.26.024.
[20] Jin J, Sklar GE, Min Sen Oh V, et al. Factors affecting therapeutic compliance: a review from the patient's perspective[J]. Ther Clin Risk Manag,2008,4(1):269-286. DOI:10.2147/tcrm.s1458.
[21] Wileman V, Farrington K, Wellsted D, et al. Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients[J]. Br J Health Psychol,2015,20(3):563-578. DOI:10.1111/bjhp.12116.
[22] 张帆,李敏,邱茂琪,等. 血液透析患者血磷管理效能及遵医行为对血磷水平的影响[J]. 护理学杂志,2018,33(9):37-39. DOI:10.3870/j.issn.1001-4152.2018.09.037.
[23] Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives[J]. Patient Prefer Adherence,2018,12:1175-1191. DOI:10.2147/PPA.S145648.
[24] 汪玲珍,林静霞,彭鹿,等. 腹膜透析合并高磷血症患者服用降磷药物依从性的质性研究[J]. 中国中西医结合肾病杂志,2020,21(12):1098-1100. DOI:10.3969/j.issn.1009- 587X.2020.12.021.
[25] Hjemas BJ, Bovre K, Mathiesen L, et al. Interventional study to improve adherence to phosphate binder treatment in dialysis patients[J]. BMC Nephrol,2019,20(1):178. DOI:10.1186/s12882-019-1334-x.
[26] 梁凯婷,黄树生,梁谋,等. 维持性血液透析患者治疗不依从性原因的质性研究[J]. 国际医药卫生导报,2019,25(12):1900-1903. DOI:10.3760/cma.j.issn.1007-1245.2019.12.014.
[27] Ohya M, Iwashita Y, Kunimoto S, et al. An analysis of medication adherence and patient preference in long-term stable maintenance hemodialysis patients in Japan[J]. Intern Med,2019,58(18):2595-2603. DOI:10.2169/internalmedicine.2676-19.
[28] De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action[J]. Eur J Cardiovasc Nurs,2003,2(4):323. DOI:10.1016/S1474-5151(03)00091-4.
[29] 张淑,王建宁,周松,等. 血液透析护士对患者服药依从性认知和行为的现状调查[J]. 中国护理管理,2020,20(1):130-135. DOI:10.3969/j.issn.1672-1756.2020.01.027.
[30] Ferreira A, Pinto B, Navarro D, et al. Effectiveness of sucroferric oxyhydroxide in patients on on-line hemodiafiltration in real-world clinical practice: a retrospective study[J]. J Bras Nefrol,2019,41(2):224-230. DOI:10.1590/2175-8239-JBN-2018-0142.
[31] Floege J, Covic AC, Ketteler M, et al. One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis[J]. Nephrol Dial Transplant,2017,32(11):1918-1926. DOI:10.1093/ndt/gfw460.
[32] Ogata H, Fukagawa M, Hirakata H, et al. Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial[J]. JAMA,2021,325(19):1946-1954. DOI:10.1001/jama.2021.4807.
[33] Gasu V, Ashong M, Seferi A, et al. Effectiveness of phosphate binders in adult patients with end stage renal disease receiving hemodialysis: a systematic review[J]. JBI Database System Rev Implement Rep,2019,17(1):49-73. DOI:10.11124/JBISRIR-2017-003740.
[34] Martins MT, Silva LF, Kraychete A, et al. Potentially modifiable factors associated with non-adherence to phosphate binder use in patients on hemodialysis[J]. BMC Nephrol,2013,14:208. DOI:10.1186/1471-2369-14-208.
[35] Milazi M, Bonner A, Douglas C. Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review[J]. JBI Database System Rev Implement Rep,2017,15(4):971-1010. DOI:10.11124/JBISRIR-2017-003360.
[36] Milazi M, Douglas C, Bonner A. A bundled phosphate control intervention (4Ds) for adults with end-stage kidney disease receiving haemodialysis: a cluster randomized controlled trial[J]. J Adv Nurs,2021,77(3):1345-1356. DOI:10.1111/jan.14700.
[37] Kalantar-Zadeh K. Patient education for phosphorus management in chronic kidney disease[J]. Patient Prefer Adherence,2013,7:379-390. DOI:10.2147/PPA.S43486.
[38] Suzuki H, Uchida S, Kashiwagura Y, et al. Impact of community pharmacist-led intensive education on the control of serum phosphate levels in haemodialysis patients[J]. Int J Clin Pharm,2021,43(1):220-228. DOI:10.1007/s11096-020-01136-8.
[39] 朱金荣,门海燕,赵微微,等. 强化健康教育在持续反复高磷血症血液透析患者中的应用[J]. 中国护理管理,2018,18(8):1148-1152. DOI:10.3969/j.issn.1672-1756.2018.08.030.
[40] 许世林,刘云,文罗娜,等. 多学科协作干预方案对维持性血液透析伴高磷血症患者血磷的影响[J]. 护理学报,2020,27(6):61-64. DOI:10.16460/j.issn1008-9969. 2020. 06.061.
[41] Levensky ER, Forcehimes A, O'Donohue WT, et al. Motivational interviewing: an evidence-based approach to counseling helps patients follow treatment recommendations[J]. Am J Nurs,2007,107(10):50-58, 58-59. DOI:10.1097/01.NAJ.0000292202.06571.24.
[42] García-Llana H, Remor E, Del PG, et al. Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease[J]. J Clin Psychol Med Settings,2014,21(1):103-115. DOI:10.1007/s10880-013-9383-y.
[43] Brauer A, Waheed S, Singh T, et al. Improvement in hyperphosphatemia using phosphate education and planning talks[J]. J Ren Nutr,2019,29(2):156-162. DOI:10.1053/j.jrn.2018.06.004.
[44] 程颖,陈庚,张丽华,等. 认知行为干预对血液透析伴高磷血症病人疾病知识及自护能力的影响[J]. 全科护理,2018,16(30):3718-3721. DOI:10.12104/j.issn.1674-4748. 2018.30.001.
[45] 周宇,刘梦雅,高莉莉,等. 基于信息化的服药依从性促进工具研究进展[J]. 护理研究,2020,34(23):4186-4190. DOI:10.12102/j.issn.1009-6493.2020.23.014.
[46] 卫诺,陈伟红,张晓娜,等. 短信平台教育在提高慢性肾脏病患者服药依从性中的应用研究[J]. 中国全科医学,2013,16(19):2287-2289. DOI:10.3969/j.issn.1007-9572. 2013. 19.029.
[47] 彭一航,谢莉玲,梁燕,等. 智能药物管理系统在养老机构老年人中的应用[J]. 中华护理杂志,2021,56(5):680-686. DOI:10.3761/j.issn.0254-1769.2021.05.006.

Research progress on influencing factors and intervention of phosphate binder medication adherence in hemodialysis patients

血液透析患者服用磷结合剂依从性的影响因素及干预研究进展

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 10

Recommended Articles

Metrics

[1]	Zhang Lifeng, Huang Xuefeng, Pan Huijuan. Effect of internet technology nursing on self-management ability of vascular access in hemodialysis patients [J]. International Medicine and Health Guidance News, 2022, 28(21): 3059-3059.
[2]	Zhong Liping, Tang Jiamin, Su Caihong, Kuang Qiutian, Li Jialin, Su Yanyan. Effect of fine nursing intervention on weight control of maintenance hemodialysis patients during the interdialytic period [J]. International Medicine and Health Guidance News, 2022, 28(18): 2591-2595.
[3]	Yang Qijun, Jin Huiping, Duan Xia, Wang Jianmei. Observation on the effect of trocar in arteriovenous graft for dialysis patients [J]. International Medicine and Health Guidance News, 2022, 28(18): 2635-2638.
[4]	Wang Jiao, Zhang Haiyan, Zhang Qi, Liu Hongchao, Hu Xueping. Summary of best evidences of dietary quality management in stage 5 CKD patients undergoing hemodialysis [J]. International Medicine and Health Guidance News, 2022, 28(16): 2351-2355.
[5]	Zhao Yinghui, Sun Yi, Zheng Hua, Shi Gaoyue. Effect of sacubitril/valsartan on chronic congestive heart failure in maintenance hemodialysis patients [J]. International Medicine and Health Guidance News, 2022, 28(14): 1940-1944.
[6]	Ren Xiang, Zhang Liyuan. Effect of statins on survival and prognosis in maintenance hemodialysis patients [J]. International Medicine and Health Guidance News, 2022, 28(14): 1945-1950.
[7]	Ye Yuling, Yang Min, Qiu Wanling, Huang Chaoming, Fang Kunyang, Lin Jingxia, Peng Lu. Mediating effect of resilience on medical treatment adherence and quality of life among maintenance hemodialysis patients [J]. International Medicine and Health Guidance News, 2022, 28(14): 1951-1954.
[8]	Deng Meizhi, Wang Cun, He Jingzhao, Tang Xingming, Zhao Zhenzhi, Fu Xinlei. Application of intermittent peritoneal dialysis in early treatment for severe pancreatitis [J]. International Medicine and Health Guidance News, 2022, 28(14): 1986-1990.
[9]	Lei Zihan, Wang Yuquan, Su Yanyan, Chen Siqi, Wang Qi, Yang Shen. Correlation between PTH and hs-cTnI levels in patients undergoing single-center maintenance hemodialysis [J]. International Medicine and Health Guidance News, 2022, 28(12): 1670-1673.
[10]	Yu Rong, Zhang Yuyu, Wu Chunying, Chen Xia. The relationship between self-management level and quality of life in maintenance hemodialysis patients [J]. International Medicine and Health Guidance News, 2021, 27(6): 825-827.